The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis

AIMS: Optimal medical therapy after cardiac resynchronization therapy (CRT) implantation is important in heart failure (HF) with reduced ejection fraction (HFrEF) patients. Although sacubitril/valsartan (SV) is a mainstay in the treatment of HFrEF, its efficacy in the management of CRT non‐responder...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Kyeong‐Hyeon, Oh, Jaewon, Yu, Hee Tae, Lee, Chan Joo, Kim, Tae‐Hoon, Uhm, Jae Sun, Pak, Hui‐Nam, Lee, Moon‐Hyoung, Joung, Boyoung, Kang, Seok‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755012/
https://www.ncbi.nlm.nih.gov/pubmed/32918402
http://dx.doi.org/10.1002/ehf2.12988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755012/
https://www.ncbi.nlm.nih.gov/pubmed/32918402
http://dx.doi.org/10.1002/ehf2.12988

Ejemplares similares